Saturday, 31 October 2026European Markets

ALAN ALLMAN Stock Was Up By 10% On Tuesday

Loading stream...

(vianews) - the market ended the session with alan allman (aaa.pa) jumping 10% to €6.60 on tuesday while cac 40 slid 0.93% to €7,575.10.

alan allman's last close was €6.00, 54.2% below its 52-week high of €13.10.

about alan allman

alan allman associates, together with its subsidiaries, engages in the provision of consulting services in canada, france, belgium, luxembourg, switzerland, and singapore. the company offers technology consulting in the areas, including cybersecurity, cloud, data management, digitalization of tools and processes, etc.; strategy and management consulting comprising risk management, commercial intelligence, market finance, process management, change management, etc.; and industrial transformation consulting, such as purchasing and supply chain issues, relocation, cost reduction, project management, materials, process consulting, etc. the company was incorporated in 1954 and is based in issy-les-moulineaux, france.

earnings per share

as for profitability, alan allman has a trailing twelve months eps of €0.13.

pe ratio

alan allman has a trailing twelve months price to earnings ratio of 50.77. meaning, the purchaser of the share is investing €50.77 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.5%.

volatility

alan allman's last week, last month's, and last quarter's current intraday variation average was a negative 1.24%, a negative 2.13%, and a positive 2.56%.

alan allman's highest amplitude of average volatility was 2.97% (last week), 2.76% (last month), and 2.56% (last quarter).

yearly top and bottom value

alan allman's stock is valued at €6.60 at 22:30 est, way below its 52-week low of €8.44.

moving average

alan allman's value is way below its 50-day moving average of €9.88 and way under its 200-day moving average of €10.73.

volume

today's last reported volume for alan allman is 2178 which is 423.55% above its average volume of 416.

more news about alan allman (aaa.pa).

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com